suvorexant 15 MG Oral Tablet

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

suvorexant 15 MG Oral Tablet

15 MG · Oral Tablet · oral

A form of suvorexant →

suvorexant 15 MG Oral Tablet — Orexin receptor antagonists. Strength, form, class, interactions & more.

suvorexant 15 MG Oral Tablet

Active ingredient

Classification

Orexin receptor antagonistsOrexin Receptor Antagonist

Drug interactions

Suvorexant has several drug interactions that may affect its efficacy and safety.

  • majorCYP3A inhibitors — Recommended dose is 5 mg when used with moderate CYP3A inhibitors; not recommended with strong CYP3A inhibitors.
  • majorCYP3A inducers — Efficacy may be reduced when co-administered with strong CYP3A inducers.
  • moderatedigoxin — Monitor digoxin concentrations due to slight increase in levels.
  • moderatealcohol — Additive psychomotor impairment demonstrated.
  • majorgrapefruit juice — Recommended dose is 5 mg when used with moderate CYP3A inhibitors.

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.